High-oleic soybean could give biotech industry a boost

11/18/2013 | New York Times (tiered subscription model), The

High-oleic, trans fat-free oil from soybeans developed by Monsanto and DuPont Pioneer may bolster the image of the biotechnology industry in light of the U.S. Food and Drug Administration's recent proposed ban on trans fatty acids, experts say. The United Soybean Board is investing $60 million to develop and market the genetically modified soybeans in an effort to regain market share lost to canola and palm oils, after the FDA began requiring artificial trans fats to be included on food labels in 2003. Both companies' beans block the conversion of oleic fatty acid into linoleic acid, and Monsanto's beans also have lower levels of saturated fats.

View Full Article in:

New York Times (tiered subscription model), The

Published in Brief: